U.S. Markets closed

FSD Pharma Inc. (HUGE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.1400+0.5900 (+38.06%)
At close: 4:00PM EST

2.1900 +0.05 (2.34%)
After hours: 4:32PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.5500
Open1.6600
Bid2.1100 x 1400
Ask2.1400 x 1000
Day's Range1.6600 - 2.3700
52 Week Range1.2800 - 14.0000
Volume16,731,271
Avg. Volume449,617
Market Cap42.715M
Beta (5Y Monthly)0.73
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update
    Business Wire

    FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update

    FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) ("FSD Pharma" or the "Company") today announced its financial results for the third quarter ending September 30, 2020 and provided a corporate update. The filing is available on SEDAR.

  • FSD Pharma Announces Settlement of Class Action Proceeding
    Business Wire

    FSD Pharma Announces Settlement of Class Action Proceeding

    FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that, subject to court certification and other customary conditions, it has entered into a definitive settlement agreement (the "Settlement Agreement") with respect to the class action litigation commenced by a plaintiff shareholder in the Ontario Superior Court of Justice in February 2019 relating to the build-out of its facility in Cobourg, Ontario (the "Settled Action").

  • FSD Pharma Inc. Announces Closing of US$9.5 Million Registered Direct Offering
    Business Wire

    FSD Pharma Inc. Announces Closing of US$9.5 Million Registered Direct Offering

    FSD Pharma Inc. (Nasdaq: HUGE) ("FSD Pharma" or the "Company"), today announced the closing of previously announced definitive agreements with investors for the purchase and sale of 4,318,179 Class B Subordinate Voting Shares of the Company ("Shares") and warrants to purchase 3,454,543 Shares (collectively, the "Securities") at a purchase price of US$2.20 per Share in a registered direct offering. The warrants have an exercise price of US$2.60 per Share, are immediately exercisable and expire five years from the date of issuance.